Zimmer Biomet Holdings Inc  

(Public, NYSE:ZBH)   Watch this stock  
Find more results for NYSE:ZMH
+1.03 (0.90%)
Apr 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 114.35 - 116.44
52 week 88.27 - 117.77
Open 115.00
Vol / Avg. 0.00/1.37M
Mkt cap 23.17B
P/E 161.72
Div/yield 0.24/0.83
EPS 0.72
Shares 198.83M
Beta 0.97
Inst. own 99%
Jul 28, 2016
Q2 2016 Zimmer Biomet Holdings Inc Earnings Release (Estimated) - 7:30AM EDT - Add to calendar
May 5, 2016
Zimmer Biomet Holdings Inc at Deutsche Bank Health Care Conference - 12:50PM EDT - Add to calendar
May 4, 2016
Zimmer Holdings Inc Annual Shareholders Meeting (Estimated) - 8:00AM EDT - Add to calendar
May 3, 2016
Zimmer Biomet Holdings Inc Annual Shareholders Meeting - 8:00AM EDT - Add to calendar
Apr 28, 2016
Q1 2016 Zimmer Biomet Holdings Inc Earnings Call - Webcast
Apr 28, 2016
Q1 2016 Zimmer Biomet Holdings Inc Earnings Release
Mar 16, 2016
Zimmer Biomet Holdings Inc at Barclays Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 6.55% 2.44%
Operating margin 11.04% 7.79%
EBITD margin - 33.54%
Return on average assets 1.89% 0.79%
Return on average equity 5.12% 1.79%
Employees 17,500 -
CDP Score - 62 E


345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Daniel P. Florin Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Stuart G. Kleopfer President, Americas
Age: 53
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D. Ph.D. President, Europe, Middle East and Africa
Age: 52
Bio & Compensation  - Reuters
Sang Yi President, Asia Pacific
Age: 54
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tony W. Collins Chief Accounting Officer, Vice President, Corporate Controller
Age: 47
Bio & Compensation  - Reuters
Adam Rudolph Johnson Group President, Spine, Dental, CMF and Thoracic
Age: 38
Bio & Compensation  - Reuters
David A. Nolan Jr. Group President of Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot and Ankle and Bone Healing
Age: 50
Bio & Compensation  - Reuters
Daniel E. Williamson Group President, Joint Reconstruction
Age: 50
Bio & Compensation  - Reuters